Walleye Trading LLC - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 141 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2021. The put-call ratio across all filers is 1.72 and the average weighting 0.1%.

Quarter-by-quarter ownership
Walleye Trading LLC ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q3 2023$120,246
-61.2%
122,700
-45.0%
0.00%
-100.0%
Q2 2023$310,248
-35.8%
223,200
-26.5%
0.00%0.0%
Q1 2023$482,883
-76.2%
303,700
-6.6%
0.00%
-83.3%
Q4 2022$2,025,373
-15.7%
325,100
-9.3%
0.01%
-14.3%
Q3 2022$2,402,000
+57.2%
358,570
+49.2%
0.01%
+40.0%
Q2 2022$1,528,000
+232.9%
240,300
+143.0%
0.01%
+400.0%
Q1 2022$459,000
-75.6%
98,900
-73.7%
0.00%
-85.7%
Q4 2021$1,882,000
-52.3%
376,249
+14.8%
0.01%
-50.0%
Q3 2021$3,948,000
+729.4%
327,724
+1356.6%
0.01%
+600.0%
Q2 2021$476,000
-34.8%
22,500
-13.5%
0.00%
-33.3%
Q1 2021$730,000
-4.1%
26,000
-11.3%
0.00%0.0%
Q4 2020$761,000
-4.4%
29,300
+89.0%
0.00%
-40.0%
Q2 2020$796,000
+108.4%
15,500
+28.1%
0.01%
+66.7%
Q1 2020$382,000
-68.9%
12,100
-41.3%
0.00%
-66.7%
Q4 2019$1,229,000
+110.8%
20,600
+29.6%
0.01%
+80.0%
Q3 2019$583,000
+4.5%
15,900
+32.7%
0.01%0.0%
Q2 2019$558,000
-60.8%
11,986
-66.2%
0.01%
-50.0%
Q1 2019$1,425,000
-36.3%
35,497
-27.0%
0.01%
-41.2%
Q4 2018$2,236,000
+704.3%
48,602
+584.5%
0.02%
+1600.0%
Q2 2018$278,0007,1000.00%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q3 2021
NameSharesValueWeighting ↓
Meditor Group Ltd 4,468,835$20,735,0008.65%
Altium Capital Management LP 2,496,524$11,584,0003.88%
Deep Track Capital, LP 6,000,000$27,840,0001.78%
Paradigm Biocapital Advisors LP 1,157,246$5,370,0001.42%
Monaco Asset Management SAM 419,262$1,945,0000.77%
Rhenman & Partners Asset Management AB 981,582$4,555,0000.45%
PLATINUM INVESTMENT MANAGEMENT LTD 2,713,176$12,589,0000.39%
Bellevue Group AG 4,299,164$19,948,0000.23%
WASATCH ADVISORS LP 8,147,380$37,804,0000.19%
Telemetry Investments, L.L.C. 17,500$81,0000.13%
View complete list of ESPERION THERAPEUTICS INC NE shareholders